“Cadonilimab plus lenvatinib showed promising antitumor activity in patients with advanced endometrial cancer who have experienced disease progression after prior platinum-based chemotherapy,” said Chunyan Lan, MD, PhD.
Investigators assessed whether a reported survival disadvantage in men with secondary rectal cancer following prostate cancer radiation therapy vs primary rectal cancer is due to…
Most adverse effects with fruquintinib plus BSC were low-grade and manageable, with a low rate of discontinuation, in patients with mCRC.
Study results suggest that “telemedicine represents a unique opportunity to reduce time and travel burdens for patients with cancer considering clinical trials,” according to researchers.
Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.
Prehabilitation involving a combination of exercise, nutrition, and psychological support has potential to reduce overall postoperative complications in patients undergoing surgery for upper GI cancers.
Patients reported benefit and satisfaction with pexidartinib for tenosynovial giant cell tumor management.
An analysis of 2 pharmacovigilance databases revealed a high prevalence of azacitidine-related adverse events in patients with MDS or AML.
Globally, deaths from mesothelioma increased 96.4% from 1990 to 2021.
A team of nurses created a standardized patient handoff process that improved communications between nurses and with patients.
Screening program provides timely referrals to patients with cancer for management of potential cardiotoxicities.
